Literature DB >> 16715582

Rift Valley fever in goats, Cameroon.

Matthew LeBreton, Sally Umlauf, Cyrille F Djoko, Peter Daszak, Donald S Burke, Paul Yemgai Kwenkam, Nathan D Wolfe.   

Abstract

Entities:  

Mesh:

Year:  2006        PMID: 16715582      PMCID: PMC3294709          DOI: 10.3201/eid1204.051428

Source DB:  PubMed          Journal:  Emerg Infect Dis        ISSN: 1080-6040            Impact factor:   6.883


× No keyword cloud information.
To the Editor: Rift Valley fever (RVF) is caused by an RNA virus (Phlebovirus, Bunyaviridae), which is carried by mosquito vectors (). In nature, it is only known in Africa and the Arabian Peninsula. In the central African region, RVF has been reported in humans and livestock in the savanna of northern Cameroon and Chad (,) and from forests in the Central African Republic (). Human epidemics are sometimes preceded by an increase in RVF virus (RVFV) prevalence in domestic ruminants, which manifests as increased abortions and high neonatal deaths (). Human epidemics can have serious health implications, as demonstrated by the most recent outbreaks in Kenya in 1997 and 1998 () and Saudi Arabia in 2001 (). In June 2003, 14 goats from an urban market in Yaoundé (3.9°N, 11.5°E), Cameroon, and 36 goats from 3 adjacent villages in tropical lowland rainforest ≈80 km south of Mvangan (2.4°N, 11.8°E), Cameroon, were sampled. The goats in the rural villages were bred locally and allowed to roam freely throughout the villages. No vaccinations had been given to goats in the rural sites. Goats in the urban market in Yaoundé generally originated in northern Cameroon and had been transported by train to Yaoundé. Owners did not report high levels of abortion or high neonatal deaths. Jugular blood was collected in a 5-mL dry Vacutainer tube and centrifuged within 48 hours of collection. The frozen sera were shipped on ice to the Onderstepoort Veterinary Institute, the United Nations Food and Agriculture Organization reference laboratory for RVFV. An indirect enzyme-linked immunosorbent assay (I-ELISA) was used to detect RVFV immunoglobulin G (IgG) antibodies in 26 samples. In this assay, optical density readings were converted to a percentage of high-positive control serum (PP) and positive samples were those with PP >10. These samples were further tested with RVFV hemagglutination inhibition (HI), and samples with titers >20 were considered seropositive (). Positive I-ELISA and HI samples were confirmed by using a serum neutralization (SN) assay (,). A sample was considered seropositive when it had an SN titer of >4, determined during experiments on laboratory-injected sheep (–) and testing of wild and domestic African ruminants (). The SN assay has been shown to be highly specific; cross-reactivity with other viruses from the family Bunyaviridae is not likely (). Of the 26 goat samples tested for RVFV, 6 tested positive to RVFV (Table). Samples from 5 goats from the rural villages and 1 from the urban market had RVFV IgG PP >10. Samples from 2 goats from the rural villages had high RVFV HI titers (320 and 5,120). Three of the 6 samples from the rural villages with high IgG PP and HI titers had elevated neutralization titers (>4).
Table

Site, age, and sex of goat samples positive for Rift Valley fever virus*

SiteAge, ySexI-ELISA PPHI titerSN titer
Market1.5F10/
Rural3M14/
Rural3.5F15/
Rural4F16/
Rural4.5M354
Rural3F/3208
Rural2F1065,12012

*By indirect enzyme-linked immunosorbent assay (I-ELISA), hemagglutination inhibition (HI), and serum neutralization (SN); PP, optical density expressed as a percentage of high-positive control serum; /, not tested; –, negative.

*By indirect enzyme-linked immunosorbent assay (I-ELISA), hemagglutination inhibition (HI), and serum neutralization (SN); PP, optical density expressed as a percentage of high-positive control serum; /, not tested; –, negative. The results indicate for the first time that RVFV is present in forests of southern Cameroon. Given the ages of the seropositive goats (2, 3, and 4.5 years), transmission of the virus occurred recently. In savanna goat herds in northern Cameroon, RVFV IgG prevalence has been reported at 9% to 20% (). To determine prevalence of RVFV in goats in southern Cameroon, more animals need to be sampled; the small sample size and isolation of the few rural villages are unrepresentative. The presence of RVFV antibodies in domestic animals suggests that this virus may also be circulating in human populations, despite the absence of reports. A study of 21 persons in Ngoïla in southern Cameroon found no RVFV antibodies during a bloody diarrhea epidemic in 1998 (,); however, testing facilities for RVFV are not available in Cameroon, and the general population and healthcare providers have limited awareness of the virus and associated disease. Central African forests have a high diversity of forest ungulates (>10 species), and RVFV has been reported from a number of wild African ungulates (). The potential for exchange of RVFV and other pathogens between goats and wild ungulates could have substantial effects on animal production and on the conservation of wild species, some of which are considered near-threatened. Livestock disease surveillance can play a role not only in assessing the distribution of livestock pathogens but also in monitoring disease emergence.
  10 in total

1.  [Microbiological surveillance: viral hemorrhagic fever in Central African Republic: current serological data in man].

Authors:  E Nakounné; B Selekon; J Morvan
Journal:  Bull Soc Pathol Exot       Date:  2000-01

2.  Enterohaemorrhagic Escherichia coli in Ngoïla (Cameroon) during an outbreak of bloody diarrhoea.

Authors:  Y Germani; P Cunin; E Tedjouka; C B Ncharre; J Morvan; P Martin
Journal:  Lancet       Date:  1998-08-22       Impact factor: 79.321

3.  Comparison of techniques for demonstrating antibodies to Rift Valley fever virus.

Authors:  R Swanepoel; J K Struthers; M J Erasmus; S P Shepherd; G M McGillivray; B J Erasmus; B J Barnard
Journal:  J Hyg (Lond)       Date:  1986-10

4.  Rift Valley fever antibody prevalence in domestic ungulates in Cameroon and several west African countries (1989-1992) following the 1987 Mauritanian outbreak.

Authors:  H G Zeller; R Bessin; Y Thiongane; I Bapetel; K Teou; M G Ala; A N Atse; R Sylla; J P Digoutte; J A Akakpo
Journal:  Res Virol       Date:  1995 Jan-Feb

Review 5.  Rift Valley fever: an uninvited zoonosis in the Arabian peninsula.

Authors:  Hanan H Balkhy; Ziad A Memish
Journal:  Int J Antimicrob Agents       Date:  2003-02       Impact factor: 5.283

6.  Comparative pathogenicity and antigenic cross-reactivity of Rift Valley fever and other African phleboviruses in sheep.

Authors:  R Swanepoel; J K Struthers; M J Erasmus; S P Shepherd; G M McGillivray; A J Shepherd; D E Hummitzsch; B J Erasmus; B J Barnard
Journal:  J Hyg (Lond)       Date:  1986-10

7.  An outbreak of Rift Valley fever in Northeastern Kenya, 1997-98.

Authors:  Christopher W Woods; Adam M Karpati; Thomas Grein; Noel McCarthy; Peter Gaturuku; Eric Muchiri; Lee Dunster; Alden Henderson; Ali S Khan; Robert Swanepoel; Isabelle Bonmarin; Louise Martin; Philip Mann; Bonnie L Smoak; Michael Ryan; Thomas G Ksiazek; Ray R Arthur; Andre Ndikuyeze; Naphtali N Agata; Clarence J Peters
Journal:  Emerg Infect Dis       Date:  2002-02       Impact factor: 6.883

8.  Indirect enzyme-linked immunosorbent assay for the detection of antibody against Rift Valley fever virus in domestic and wild ruminant sera.

Authors:  J T Paweska; S J Smith; I M Wright; R Williams; A S Cohen; A A Van Dijk; A A Grobbelaar; J E Croft; R Swanepoel; G H Gerdes
Journal:  Onderstepoort J Vet Res       Date:  2003-03       Impact factor: 1.792

9.  New vectors of Rift Valley fever in West Africa.

Authors:  D Fontenille; M Traore-Lamizana; M Diallo; J Thonnon; J P Digoutte; H G Zeller
Journal:  Emerg Infect Dis       Date:  1998 Apr-Jun       Impact factor: 6.883

10.  Rift Valley fever in Chad.

Authors:  David Ringot; Jean-Paul Durand; Hugues Toulou; Jean-Paul Boutin; Bernard Davoust
Journal:  Emerg Infect Dis       Date:  2004-05       Impact factor: 6.883

  10 in total
  9 in total

1.  Seroprevalence of Rift Valley fever virus in cattle in the Democratic Republic of the Congo.

Authors:  Georges Mbuyi Tshilenge; William G Dundon; Marco De Nardi; Leopold K Mulumba Mfumu; Mark Rweyemamu; Jean-Marie Kayembe-Ntumba; Justin Masumu
Journal:  Trop Anim Health Prod       Date:  2018-10-22       Impact factor: 1.559

2.  Translating Predictions of Zoonotic Viruses for Policymakers.

Authors:  Seth D Judson; Matthew LeBreton; Trevon Fuller; Risa M Hoffman; Kevin Njabo; Timothy F Brewer; Elsa Dibongue; Joseph Diffo; Jean-Marc Feussom Kameni; Severin Loul; Godwin W Nchinda; Richard Njouom; Julius Nwobegahay; Jean Michel Takuo; Judith N Torimiro; Abel Wade; Thomas B Smith
Journal:  Ecohealth       Date:  2017-12-11       Impact factor: 3.184

3.  A Cross-Sectional, Population-Based, Seroepidemiological Study of Rift Valley Fever in Cameroonian Cattle Populations.

Authors:  Barend Mark Bronsvoort; Robert Francis Kelly; Emily Freeman; Rebecca Callaby; Jean Marc Bagninbom; Lucy Ndip; Ian Graham Handel; Vincent Ngwang Tanya; Kenton Lloyd Morgan; Victor Ngu Ngwa; Gianluigi Rossi; Charles K Nfon; Stella Mazeri
Journal:  Front Vet Sci       Date:  2022-06-14

4.  Serological evidence of rift valley fever Phlebovirus and Crimean-Congo hemorrhagic fever orthonairovirus infections among pygmies in the east region of Cameroon.

Authors:  Serge Alain Sadeuh-Mba; Gide Martial Yonga Wansi; Maurice Demanou; Antoine Gessain; Richard Njouom
Journal:  Virol J       Date:  2018-04-06       Impact factor: 4.099

Review 5.  An update on the mosquito fauna and mosquito-borne diseases distribution in Cameroon.

Authors:  Roland Bamou; Marie Paul Audrey Mayi; Borel Djiappi-Tchamen; Stella Mariette Nana-Ndjangwo; Elysée Nchoutpouen; Antony John Cornel; Parfait Awono-Ambene; Phillipe Parola; Timoléon Tchuinkam; Christophe Antonio-Nkondjio
Journal:  Parasit Vectors       Date:  2021-10-11       Impact factor: 3.876

6.  Seroprevalence of Rift Valley fever virus in domestic ruminants of various origins in two markets of Yaoundé, Cameroon.

Authors:  Francine Yousseu Sado; Huguette Simo Tchetgna; Basile Kamgang; Doumani Djonabaye; Emmanuel Nakouné; Philip J McCall; Roland Ndip Ndip; Charles S Wondji
Journal:  PLoS Negl Trop Dis       Date:  2022-08-11

7.  Serological evidence of the circulation of the Rift Valley fever virus in sheep and goats slaughtered in Yaoundé, Cameroon.

Authors:  Jean Thierry Ebogo-Belobo; Serge Alain Sadeuh-Mba; Georges Marc Arthur Mveng-Sanding; Gwladys Monamele Chavely; Martin H Groschup; Wilfred Fon Mbacham; Richard Njouom
Journal:  Vet Med Sci       Date:  2022-05-20

8.  Rift valley fever in humans and animals in Mayotte, an endemic situation?

Authors:  Tinne Lernout; Eric Cardinale; Maël Jego; Philippe Desprès; Louis Collet; Betty Zumbo; Emmanuel Tillard; Sébastien Girard; Laurent Filleul
Journal:  PLoS One       Date:  2013-09-30       Impact factor: 3.240

9.  Seroprevalence and Associated Risk Factors of Rift Valley Fever in Domestic Small Ruminants in the North Region of Cameroon.

Authors:  R Poueme; F Stoek; N Nloga; J Awah-Ndukum; M Rissmann; A Schulz; A Wade; J Kouamo; M Moctar; A Eisenbarth; L God-Yang; S Dickmu; M Eiden; M H Groschup
Journal:  Vet Med Int       Date:  2019-11-25
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.